Cyprus Mail
Cyprus

Cross examination of Lillis completed

DEFENCE lawyers in the controversial CyTA land acquisition deal in Dromolaxia on Thursday concluded the cross-examination of entrepreneur Nicos Lillis, the prosecution’s main witness.

Kyriakos Mouskos, defence lawyer of businessman and shareholder of Wadnic Trading Ltd, Antonis Ioakim, asked Lillis about his client’s involvement in the case.

In previous days, Lillis had named Ioakim as the person who allegedly put him in contact with prominent AKEL members Venizelos Zanettos and Christos Alekou. Lillis had testified that the two of them asked him to make “hefty donations” to the party in exchange for easing the land acquisition.

Mouskos wondered how Lillis needed someone to arrange a meeting with party members, since, as he had testified before, he had connections within the party.

Asked whether Ioakim pressured him to pay off the debts of Alki football club, a team Lillis was a president of, Lillis replied that it would be absurd, since Ioakim and Lillis were business partners.

The trial will resume on April 30 with another prosecution witness.

The land in Dromolaxia was paid for by the state telecoms CyTA employees’ pension fund. The seven defendants face 28 charges relating to the alleged embezzlement of €22.5m to build four office complexes – the ‘Aero Centre’ – from the CyTA employees’ pension fund.

The accused are former CyTA chairman Stathis Kittis, Charalampos Tsouris, former CyTA board member, Orestis Vasiliou, former secretary general of CyTA’s employee union, Yiannis and Gregoris Souroullas, AKEL member Venizelos Zannetos, Antonis Ioakim, and Polleson Holdings Ltd.

Related Posts

Group seeks state land for stray cats

Anna Savva

Number of cases in ‘subsidies scam’ rises to 49, two women re-remanded

Staff Reporter

Former TC leader Eroglu admitted to hospital

Staff Reporter

Rehabilitating hormone replacement

Gina Agapiou

Glimpse a world beneath the waves

Anna Savva

Over 900 traffic fines issued in 48 hours

Staff Reporter

1 comment

Comments are closed.